Physician profile
John Robert Harris
NPI 1962794354
$7,004.43
in general payments reported to CMS, 2019-2025
23 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,326 · 2020: $985 · 2021: $105 · 2022: $323 · 2023: $502 · 2024: $171 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,265.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,675.69 | 2019-2024 | |
| Arthrex, INC. | $2,453.16 | 2019 | |
| Smith+Nephew, INC. | $530.31 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Pico 7, Q-Fix |
| Stryker Corporation | $455.74 | 2019-2025 | Iconix, Variax, Actishield |
| Depuy Synthes Sales INC. | $196.66 | 2021-2025 | Monovisc, Orthovisc, Na |
| Zimmer Biomet Holdings, INC. | $99.05 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $95.75 | 2022-2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $67.86 | 2025 | |
| Globus Medical, INC. | $67.22 | 2022-2023 | Distal Femur Plate System |
| Cumberland Pharmaceuticals, INC. | $53.73 | 2019-2023 | Caldolor |
| Kowa Pharmaceuticals America, INC. | $48.64 | 2023 | Seglentis |
| Vericel Corporation | $38.15 | 2019-2022 | |
| Ethicon US, LLC | $35.50 | 2023 | Vistaseal |
| Kerecis Limited | $30.74 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Orthofix Medical, INC. | $28.57 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $21.14 | 2022 | |
| Axsome Therapeutics, INC. | $19.57 | 2023 | Auvelity |
| Sanara Medtech INC. | $17.68 | 2022 | |
| Heron Therapeutics, INC. | $17.45 | 2023 | Zynrelef |
| Cpm Medical Consultants, LLC | $15.20 | 2025 | Sterizo Total Knee System |
| Glaxosmithkline, LLC. | $12.44 | 2022 | |
| Bausch Health US, LLC | $12.27 | 2021 | |
| Alafair Biosciences, INC. | $11.91 | 2025 | Versawrap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.